Elevated serum levels of astroglial S100β in patients with liver cirrhosis indicate early and subclinical portal-systemic encephalopathy

Metabolic Brain Disease

Volumn 14, Issue 4, 1999, Pages 239-251

  Wiltfang, Jens ^a   Nolte, Wilhelm ^a   Otto, Markus ^a   Wildberg, Jens ^a   Bahn, Erik ^a   Figulla, Hans Reiner ^a   Pralle, Lars ^a   Hartmann, Heinz ^a   Rüther, Eckhard ^a   Ramadori, Giuliano ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Hepatic encephalopathy (HE); Portal systemic encephalopathy (PSE); S100 ; Transjugular intrahepatic portosystemic stent shunt(TIPS)

Indexed keywords

AMMONIA; CALCIUM BINDING PROTEIN; PROTEIN S 100;

ADULT; AGED; AMMONIA BLOOD LEVEL; ARTICLE; ASTROCYTE; CLINICAL ARTICLE; COGNITIVE DEFECT; DIAGNOSTIC ACCURACY; DISEASE COURSE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MACROGLIA; MALE; PORTOSYSTEMIC ANASTOMOSIS; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SCORING SYSTEM;

EID: 0033506555     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020785009005     Document Type: Article

References (49)

1. Butterworth, R.F. (1996). The neurobiology of hepatic encephalopathy. Semin. Liver Dis. 16:235-44.
2. Conn, H.O. (1977). Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am. J. Dig. Dis. 22:541-50.
3. Conn, H.O., and Bircher, J. (1994). Hepatic encephalopathy: syndromes and therapies. Medi-Ed Press, Bloomington, Illinois.
4. Cordoba, J., Gottstein, J., and Blei, A.T. (1996). Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema. Hepatology 24:919-23.
5. Davies, A.D.M. (1968). The influence of age on trail making test performance. J. Clin. Psychol. 24:96-8.
6. Forster, J., Delcore, R., Payne, K.M., and Siegel, E.L. (1994). The role of transjugular intrahepatic portosystemic shunts in the management of patients with end-stage liver disease. Am. J. Surg. 168:592-97.
7. Giulian, D., Woodward, J., Young, D.G., Krebs, J.F., and Lachman, L.B. (1988). Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8:2485-90.
8. Groeneweg, M., Quero, J.C., Essink-Bot, M.L., Hop, W.C.J., and Schalm S.W. (1997). The effect of Subclinical Hepatic Encephalopathy on the Quality of Life. In (C. Record and H. Al-Mardini, eds.), Advances in Hepatic Encephalopathy and Metabolism in Liver Disease, Ipswich Book Company, Newcastle upon Tyne, Great Britain, pp. 311-17.
9. Jabbour, N., Zajko, A.B., Orons, P.D., Irish, W., Bartoli, F., Marsh, W.J., Dodd, G.D., Aldreghitti. L., Colangelo, J., Rakela, J. and Fung, J.J. (1996). Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients. Liver Transpl. Surg. 2:139-47.
10. Jalan, R., Elton, R.A., Redhead, D.N., Finlayson, N.D., and Hayes, P.C. (1995). Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal hemorrhage. J. Hepatol 23:123-8.
11. Jalan, R., Gooday, R., Carroll, R.E., Redhead, D.N., Elton, R.A., and Hayes P.C. (1995). A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt. J. Hepatol 23:697-705.
12. Kimura, T., and Budka, H. (1986). Glial fibrillary acidic protein and S-100 protein in human hepatic encephalopathy: immunocytochemical demonstration of dissociation of two glia-associated proteins. Acta Neuropathol. (Berl) 70:17-21.
13. Laubenberger, J., Haussinger, D., Bayer, S., Gufler, H., Hennig, J., and Langer, M. (1997). Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 112:1610-6.
14. Lezak, M. (1995). Neuropsychological assessment. Oxford Univ. Press New York.
15. Marshak, D.R., Pesce, S.A., Stanley, L.C., and Griffin, W.S. (1992). Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiol. Aging 13:1-7.
16. Martin, H., Voss, K., Hufnagl, P., Wack, R., and Wassilew, G. (1987). Morphometric and densitometric investigations of protoplasmic astrocytes and neurons in human hepatic encephalopathy. Exp. Pathol. 32:241-250.
17. Metz, C.E. (1978). Basic principles of ROC analysis. Semin. Nucl. Med. 8:283-98.
18. Morgan, M.Y. (1996). Noninvasive neuroinvestigation in liver disease. Semin. Liver Dis. 16:293-314.
19. Mrak, R.E., Sheng, J.G., and Griffin, W.S. (1995). Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum. Pathol. 26:816-23.
20. Nolte, W., Wiltfang, J., Schindler, C., Münke, H., Unterberg, K., Figulla, H.R., Werner, G., Hartmann, H., and Ramadori, G. (1998). Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis: clinical, laboratory, psychometric and electroencephalographic investigations. Hepatology 28:1215-1225.
21. Nolte, W., Wiltfang, J.G., Kunert, H.J., Thiel, A., Geese, K., Peters, K., Figulla, H.R., Hartmann, H., and Ramadori, G. (1995). Initial clinical experiences with TIPS (transjugular intrahepatic portasystemic stent-shunt). Leber Magen Darm.25:264-6.
22. Norenberg, M.D. (1996). Astrocytic-ammonia interactions in hepatic encephalopathy. Semin. Liver Dis. 16:245-53.
23. Norenberg, M.D., Itzhak, Y., and Bender AS (1997). The peripheral benzodiazepine receptor and neurosteroids in hepatic encephalopathy. Adv. Exp. Med. Biol. 420:95-111.
24. Otto, M., Wiltfang, J., Schutz, E., Zerr, I., Otto, A., Pfahlberg, A., Gefeller, O., Uhr, M., Giese, A., Weber, T., Kretzschmar, H.A., and Poser, S. (1998). Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study. B.M.J 316:577-82.
25. Palmaz, J., Garcia, F., Sibbit, R.R., Tio, F.O., Kopp, D.T., Schwesinger, W., Lancaster, J.L., and Chang, P. (1986). Expandable intrahepatic portosystemic shunt stents in dogs with chronic portal hypertension. Am. J. Roentgenol 147:1251-54.
26. Paquet, K.J., Lazar, A., Koussouris, P., Hotzel, B., Gad, H.A., Kuhn, R. and Kalk, J.F. (1995). Mesocaval interposition shunt with small-diameter polytetrafluoroethylene grafts in sclerotherapy failure. Br. J. Surg. 82:199-203.
27. Parsons-Smith, G., Summerskill, W.H.J., Dawson, A.M., and Sherlock S (1957). The electroencephalograph in liver disease. Lancet 2:867-871.
28. Pomier-Layrargues, G. (1996). TIPS and hepatic encephalopathy. Semin. Liver Dis. 16:315-20.
29. Pugh, R.N., Murray-Lyon, I.M., Dawson, J.L., Pietroni, M.C., and Williams, R. (1973). Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 60:646-9.
30. Quero, J.C., and Schalm SW (1996). Subclinical hepatic encephalopathy. Semin. Liver Dis. 16:321-28.
31. Rao, V.L., Giguere, J.F., Pomier Layrargues, G., and Butterworth, R.F. (1993). Increased activities of MAOa and MAOb in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Brain Res. 621:349-52.
32. Reitan, R.M. (1955). The relation of the trailmaking test to organic brain damage. J. Consult. Psychol. 19:393-94.
33. Rössle, M., Deibert, P., Haag, K., Ochs, A., Olschewski, M., Siegerstetter, V., Hauenstein, K.H., Geiger, R., Stiepak, C., Keller, W., and Blum, H.E. (1997). Randomized trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 349:1043-9.
34. Rössle, M., Siegerstetter, V., Huber, M., and Ochs, A. (1998). The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 18:73-89.
35. Rössle, M., Haag, K., Ochs, A., Sellinger, M., Noldge, G., Perarnau, J.M., Berger, E., Blum, U., Gabelmann, A., Hauenstein, K., and et al. (1994). The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N. Engl. J. Med. 330:165-71.
36. Sanyal, A.J., Freedman, A.M., Shiffman, M.L., Purdum, P.P., Luketic, V.A., and Cheatham, A.K. (1994). Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 20:46-55.
37. Schomerus, H., Hamster, W., Blunck, H., Reinhard, U., Mayer, K., and Dolle W (1981). Latent portasystemic encephalopathy. 1. Nature of cerebral functional defects and their effects on fitness to drive. Dig. Dis. Sci. 26:622-30.
38. Shashoua, V.E., Hesse, G.W., and Moore, B.W. (1984). Proteins of the brain extracellular fluid: evidence for release of S- 100 protein. J. Neurochem. 42:1536-41.
39. Sheng, J.G., Mrak, R.E., and Griffin, W.S. (1997). Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages. J. Neuropathol. Exp. Neurol. 56:285-90.
40. Sobel, R.A., DeArmond, S.J., Forno, L.S., and Eng, L.F. (1981). Glial fibrillary acidic protein in hepatic encephalopathy. An immunohistochemical study. J. Neuropathol. Exp. Neuro. 40:625-32.
41. Somberg, K.A., Riegler, J.L., LaBerge, J.M., Doherty-Simor, M.M., Bachetti, P., Roberts, J.P. and Lake, J.R. (1995). Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am. J. Gastroenterol. 90:549-55.
42. Sonnewald, U., Themen, G., and Butterworth, R.F. (1996). Portacaval anastomosis results in altered neuron - astrocytic metabolic trafficking of amino acids: evidence from 13C-NMR studies. J. Neurochem. 67:1711-7.
43. Szumanska, G., and Albrecht, J. (1997). Lectin histochemistry of the rat brain following thioacetamide-induced hepatic failure. Mol. Chem. Neuropathol. 32:163-77.
44. Tewes, U. (1991). HAWIE für Erwachsene, Revision 1991. Verlag Hans Huber, Bern, Göttingen, Toronto.
45. Van Eldik, L.J., and Zimmer, D.B. (1987). Secretion of S-100 from rat C6 gliomacells. Brain Res. 436:367-70.
46. Waterloo, K., Ingebrigtsen, T., and Romner, B. (1997). Neuropsychological function in patients with increased serum levels of protein S-100 after minor head injury. Acta Neurochir. (Wien) 139:26-31.
47. Weissenborn, K., Ruckert, N., Hecker, H., and Manns, M.P. (1998). The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy. J. Hepato.l 28:646-53.
48. Weissenborn, K., Scholz, M., Hinrichs, H., Wiltfang, J., Schmidt, F.W., and Kunkel, H. (1990). Neurophysiological assessment of early hepatic encephalopathy. Electroencephalogr. Clin. Neurophysiol 75:289-95.
49. Youden, W.J. (1950). Index rating for diagnostic tests. Cancer 3:32-5.